BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21391995)

  • 1. How useful is it clinically to analyse the K-ras mutational status for the diagnosis of exocrine pancreatic cancer? A systematic review and meta-analysis.
    Parker LA; Lumbreras B; Lopez T; Hernández-Aguado I; Porta M
    Eur J Clin Invest; 2011 Jul; 41(7):793-805. PubMed ID: 21391995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients.
    Parker LA; Porta M; Lumbreras B; López T; Guarner L; Hernández-Aguado I; Carrato A; Corominas JM; Rifà J; Fernandez E; Alguacil J; Malats N; Real FX
    Eur J Epidemiol; 2011 Mar; 26(3):229-36. PubMed ID: 21298467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras mutational status in cytohistological tissue as a molecular marker for the diagnosis of pancreatic cancer: a systematic review and meta-analysis.
    Yang J; Li J; Zhu R; Zhang H; Zheng Y; Dai W; Wang F; Shen M; Chen K; Cheng P; Zhang Y; Wang C; Wang J; Xia Y; Lu J; Zhou Y; Guo C
    Dis Markers; 2014; 2014():573783. PubMed ID: 25301978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of the diagnostic value of detecting K-ras mutation in pancreatic juice as a molecular marker for pancreatic cancer.
    Yang J; Li S; Li J; Wang F; Chen K; Zheng Y; Wang J; Lu W; Zhou Y; Yin Q; Zhang H; Guo C
    Pancreatology; 2016; 16(4):605-14. PubMed ID: 27237100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies.
    Fuccio L; Hassan C; Laterza L; Correale L; Pagano N; Bocus P; Fabbri C; Maimone A; Cennamo V; Repici A; Costamagna G; Bazzoli F; Larghi A
    Gastrointest Endosc; 2013 Oct; 78(4):596-608. PubMed ID: 23660563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of K-ras mutation analysis plus endoscopic ultrasound-guided fine-needle aspiration for differentiating diagnosis of pancreatic solid mass: a meta-analysis.
    Xu Y; Hu D; Zhu Q; Sun Y
    Chin Med J (Engl); 2014; 127(18):3296-301. PubMed ID: 25266530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer.
    Alguacil J; Porta M; Malats N; Kauppinen T; Kogevinas M; Benavides FG; Partanen T; Carrato A;
    Carcinogenesis; 2002 Jan; 23(1):101-6. PubMed ID: 11756230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses.
    Ogura T; Yamao K; Sawaki A; Mizuno N; Hara K; Hijioka S; Niwa Y; Tajika M; Kondo S; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
    Gastrointest Endosc; 2012 Apr; 75(4):769-74. PubMed ID: 22284089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer.
    Alguacil J; Porta M; Kauppinen T; Malats N; Kogevinas M; Carrato A;
    Int J Cancer; 2003 Nov; 107(4):635-41. PubMed ID: 14520703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
    Uehara H; Nakaizumi A; Tatsuta M; Baba M; Takenaka A; Uedo N; Sakai N; Yano H; Iishi H; Ohigashi H; Ishikawa O; Okada S; Kakizoe T
    Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
    Minamoto T; Mai M; Ronai Z
    Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma.
    Sekita-Hatakeyama Y; Nishikawa T; Takeuchi M; Morita K; Takeda M; Hatakeyama K; Nakai T; Uchiyama T; Itami H; Fujii T; Mitoro A; Sho M; Ohbayashi C
    PLoS One; 2018; 13(3):e0193692. PubMed ID: 29494669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined detection of K-ras mutation and CA 19-9 level in plasma of patients with pancreatic cancer].
    Dai MH; Zhao YP; Cai LX; Zhu Y
    Zhonghua Wai Ke Za Zhi; 2003 May; 41(5):332-5. PubMed ID: 12892584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
    Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
    JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer.
    Kinugasa H; Nouso K; Miyahara K; Morimoto Y; Dohi C; Tsutsumi K; Kato H; Matsubara T; Okada H; Yamamoto K
    Cancer; 2015 Jul; 121(13):2271-80. PubMed ID: 25823825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of K-ras mutation analysis for pancreaticobiliary cytology specimens with indeterminate diagnosis.
    Cai G; Mahooti S; Lipata FM; Chhieng D; Hui P
    Cancer Cytopathol; 2012 Oct; 120(5):313-8. PubMed ID: 22367918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of detection of K-ras gene mutations and CA19-9 in serum for diagnosis of pancreatic carcinoma].
    Zhang Y; Ji SR; Feng DX; Ji J; Han TQ
    Ai Zheng; 2003 Mar; 22(3):295-7. PubMed ID: 12654190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice.
    Queneau PE; Adessi GL; Thibault P; Cléau D; Heyd B; Mantion G; Carayon P
    Am J Gastroenterol; 2001 Mar; 96(3):700-4. PubMed ID: 11280537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The diagnostic value of serum carcinoma markers, fecal K-ras and p53 gene mutation in pancreatic cancers].
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):741-4. PubMed ID: 16255879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.